← Back to Clinical Trials
Recruiting NCT04512755

NCT04512755 AIMS Medical Outcomes Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04512755
Status Recruiting
Phase
Sponsor Advanced Integrative Medical Science Institute
Condition Mental Health Issue
Study Type OBSERVATIONAL
Enrollment 500 participants
Start Date 2020-07-01
Primary Completion 2025-07-01

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 500 participants in total. It began in 2020-07-01 with a primary completion date of 2025-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This epidemiologic research is being conducted as an observational prospective case series outcomes study of the use of advanced integrative specialty medical care and its effect on adult and pediatric patients with chronic or serious illnesses or mental health disorders.

Eligibility Criteria

Inclusion Criteria: * Patients enrolled in the study will meet the following criteria: 1. A new patient coming in for a first office call (FOC) or first consultation via telemedicine with an AIMS physician or advanced practice provider; 2. An established patient; 3. If over 18 years of age are able to understand study design adequately and provide signed informed consent to enrollment; 4. If younger than 18 years of age informed consent from a parent or guardian who is able to understand the study design adequately and provide signed informed consent for the pediatric patient. Exclusion Criteria: * Ineligible participants: 1. Cannot read or understand English well enough to read and sign the consent form and complete the questionnaires; 2. Unwilling to participate in the AIMS Institute observational study.

Contact & Investigator

Central Contact

Michelle Speaks, MBA

✉ mspeaks@aimsinstitute.net

📞 2064201321

Principal Investigator

Therry Eparwa, DNP, FNP-BC

PRINCIPAL INVESTIGATOR

AIMS Institute

Frequently Asked Questions

Who can join the NCT04512755 clinical trial?

This trial is open to participants of all sexes, studying Mental Health Issue. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04512755 currently recruiting?

Yes, NCT04512755 is actively recruiting participants. Contact the research team at mspeaks@aimsinstitute.net for enrollment information.

Where is the NCT04512755 trial being conducted?

This trial is being conducted at Seattle, United States.

Who is sponsoring the NCT04512755 clinical trial?

NCT04512755 is sponsored by Advanced Integrative Medical Science Institute. The principal investigator is Therry Eparwa, DNP, FNP-BC at AIMS Institute. The trial plans to enroll 500 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology